1. Deng Y, Liu W, Liu K, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020 Mar 20. DOI: 10.1097/CM9.0000000000000824

2. Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020 Dec;9(1):687-690. DOI: 10.1080/22221751.2020.1741327

3. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. DOI:10.1001/jamainternmed.2020.0994

4. American Society of Hematology. COVID-19 and coagulopathy: frequently asked questions. From the ASH website. (Version 2.0; last updated April 14, 2020) URL: https://www.hematology.org/covid-19/covid-19-andcoagulopathy (дата обращения: 04.05.2020)

5. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020 May;18(5):1023-1026. DOI: 10.1111/jth.14810

6. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr;18(4):844-847. DOI: 10.1111/jth.14768

7. Временные методические рекомендации Министерства здравоохранения РФ по профилактике, диагностике и лечению новой коронавирусной инфекции (COVID-19). Версия 6 (28.04.2020). URL: https://static-1.rosminzdrav.ru/system/attachments/attaches/000/050/116/original/28042020_%D0%9CR_COVID-19_v6.pdf (дата обращения: 04.05.2020)

8. Yale School Of Medicine. COVID-19 Treatment Algorithm. URL: https://files-profile.medicine.yale.edu/documents/e91b4e5c-ae56-4bf1-8d5fe674b6450847 (дата обращения: 04.05.2020)

9. UW Medicine COVID-19 ICU Care Guidelines 4_15_2020 URL: https://covid-19.uwmedicine.org/Screening%20and%20Testing%20Algorithms/09c%20-%20COVID-19%20ICU%20Care%20Guidelines%204_15_2020.pdf (дата обращения: 04.05.2020)

10. Yale School Of Medicine. COVID-19 Treatment Algorithm. URL: https://files-profile.medicine.yale.edu/documents/e91b4e5c-ae56-4bf1-8d5fe674b6450847 (дата обращения: 04.05.2020)

11. Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. Journal of the American College of Cardiology. 2020;75(23):2950-2973, DOI: 10.1016/j.jacc.2020.04.031

12. Mount Sinai COVID-19 Anticoagulation Algorithm. Version 1.1 (April 9, 2020). URL: https://emergencymedicinecases.com/wp-content/uploads/2020/04/COVID-19-Anticoagulation-Algorithm-version_final_1.1.pdf (дата обращения 06.05.2020)

13. Clinicaltrials.gov Search Results URL: https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=DOAC+OR+rivaroxaban+OR+apixaban+OR+dabigatran&cntry=&state=&city=&dist= (дата обращения 04.05.2020)

14. Clinicaltrials.gov NCT04351724: Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) (ACOVACT) URL: https://clinicaltrials.gov/ct2/show/NCT04351724 (дата обращения 04.05.2020)

15. Clinicaltrials.gov NCT04333407: Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. (C-19-ACS) URL: https://clinicaltrials.gov/ct2/show/NCT04333407 (дата обращения 04.05.2020)

16. Testa S, Prandoni P, Paoletti O, et al. Direct oral anticoagulant plasma levels striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience. J Thromb Haemost. 2020 Jun;18(6):1320-1323. DOI: 10.1111/jth.14871